A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
- 4 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 106 (3), 643-649
- https://doi.org/10.1007/s11060-011-0709-z
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupNeuro-Oncology, 2011
- Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant GliomaJournal of Clinical Oncology, 2009
- Phase 2 study of temozolomide in children and adolescents with recurrent central nervous system tumorsCancer, 2007
- Correlations Between O6-Methylguanine DNA Methyltransferase Promoter Methylation Status, 1p and 19q Deletions, and Response to Temozolomide in Anaplastic and Recurrent Oligodendroglioma: A Prospective GICNO StudyJournal of Clinical Oncology, 2006
- Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanineOncogene, 2006
- ZD6474, a Novel Tyrosine Kinase Inhibitor of Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor, Inhibits Tumor Growth of Multiple Nervous System TumorsClinical Cancer Research, 2005
- Phase I Study of O6-Benzylguanine and Temozolomide Administered Daily for 5 Days to Pediatric Patients With Solid TumorsJournal of Clinical Oncology, 2005
- O6-Methylguanine-DNA Methyltransferase, O6-Benzylguanine, and Resistance to Clinical Alkylators in Pediatric Primary Brain Tumor Cell LinesClinical Cancer Research, 2005
- Sensitivity of short-term cultures derived from human malignant glioma to the anti-cancer drug temozolomideAnti-Cancer Drugs, 1999